Submitted:
03 November 2025
Posted:
03 November 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study sites
2.2. Study population and recruitment
2.3. Data management and analysis
2.4. Ethical consideration
3. Results
4. Discussion
5. Conclusions
Recommendations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| HBsAg | hepatitis B surface antigen |
| HBV | Hepatitis B virus |
| aPR | prevalence ratios |
| NASCOP | National AIDS and STI Control Program |
| KEMRI | Kenya Medical Research Institute’s |
| LMIC | low- and middle-income countries |
| WHO | World Health Organization |
| HCC | Hepatocellular carcinoma |
Appendix A
Appendix A.1
| Age group | No. of participants n (%) |
No. of HBV Infected n |
Proportion (%) of HBV infected within: | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age group | The total population | The infected population | ||||||||
| ≤19 | 167 | (5.6) | 3 | (1.8) | (0.1) | (1.6) | ||||
| 20-24 | 387 | (13.0) | 14 | (3.6) | (0.5) | (7.4) | ||||
| 25-29 | 408 | (13.7) | 23 | (5.6) | (0.8) | (12.2) | ||||
| 30-34 | 366 | (12.3) | 23 | (6.3) | (0.8) | (12.2) | ||||
| 35-39 | 350 | (11.7) | 30 | (8.6) | (1.0) | (15.9) | ||||
| 40-44 | 239 | (8.0) | 20 | (8.4) | (0.7) | (10.6) | ||||
| 45-49 | 176 | (5.9) | 23 | (13.1) | (0.8) | (12.2) | ||||
| 50-54 | 215 | (7.2) | 18 | (8.4) | (0.6) | (9.5) | ||||
| 55-59 | 148 | (5.0) | 8 | (5.4) | (0.3) | (4.2 | ||||
| 60-64 | 163 | (5.5) | 9 | (5.5) | (0.3) | (4.8) | ||||
| 65-69 | 126 | (4.2) | 8 | (6.4) | (0.3) | (4.2) | ||||
| 70-74 | 119 | (4.0) | 6 | (5.0) | (0.2) | (3.2) | ||||
| 75-79 | 61 | (2.0) | 4 | (6.6) | (0.1) | (2.1) | ||||
| 80-84 | 41 | (1.4) | 0 | (0.0) | (0.0) | (0.0) | ||||
| ≥85 | 21 | (0.7) | 0 | (0.0) | (0.0) | (0.0) | ||||
| Total | 2987 | 100.0 | 189 | 6.3 | 6.3 | 100 | ||||
References
- World Health Organization. Global hepatitis report 2024: action for access in low-and middle-income countries; World Health Organization, 2024. [Google Scholar]
- Bigna, J.J.; Kenne, A.M.; Hamroun, A.; Ndangang, M.S.; Foka, A.J.; Tounouga, D.N.; et al. Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis. Infectious diseases of poverty. 2019, 8, 1–12. [Google Scholar] [CrossRef]
- Al-Busafi, S.A.; Al-Harthi, R.; Al-Naamani, K.; Al-Zuhaibi, H.; Priest, P. Risk Factors for Hepatitis B Virus Transmission in Oman. Oman Med J. 2021, 36, e287. [Google Scholar] [CrossRef]
- Spearman, C.W.; Afihene, M.; Ally, R.; Apica, B.; Awuku, Y.; Cunha, L.; et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. The Lancet Gastroenterology & Hepatology. 2017, 2, 900–909. [Google Scholar]
- Ondondo, R.O.; Muthusi, J.; Oramisi, V.; Kimani, D.; Ochwoto, M.; Young, P.; et al. Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018. PLOS ONE. 2024, 19, e0310923. [Google Scholar] [CrossRef]
- Kilonzo, S.B.; Gunda, D.W.; Mpondo, B.C.T.; Bakshi, F.A.; Jaka, H. Hepatitis B Virus Infection in Tanzania: Current Status and Challenges. J Trop Med. 2018, 2018, 4239646. [Google Scholar] [CrossRef]
- Kafeero, H.M.; Ndagire, D.; Ocama, P.; Kudamba, A.; Walusansa, A.; Sendagire, H. Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020. Archives of Public Health. 2021, 79, 167. [Google Scholar] [CrossRef]
- Ochwoto, M.; Kimotho, J.H.; Oyugi, J.; Okoth, F.; Kioko, H.; Mining, S.; et al. Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya. BMC Infectious Diseases. 2016, 16, 101. [Google Scholar] [CrossRef] [PubMed]
- Ngaira, J.A.; Kimotho, J.; Mirigi, I.; Osman, S.; Ng'ang'a, Z.; Lwembe, R.; et al. Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan Afr Med J. 2016, 24, 315. [Google Scholar]
- Songtanin, B.; Chaisrimaneepan, N.; Mendóza, R.; Nugent, K. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections. Viruses. 2024, 16, 618. [Google Scholar] [CrossRef] [PubMed]
- Brook, G.; Chawla, Y. Hepatitis viruses. Sexually Transmitted Infections-E-book. 2013, 380.
- Zoulim, F.; Mason, W.S. Reasons to consider earlier treatment of chronic HBV infections. Gut. 2012, 61, 333–336. [Google Scholar] [CrossRef] [PubMed]
- Ishizaki, A.; Bouscaillou, J.; Luhmann, N.; Liu, S.; Chua, R.; Walsh, N.; et al. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low-and middle-income countries. BMC infectious diseases. 2017, 17, 129–140. [Google Scholar] [CrossRef] [PubMed]
- Ansari, A.; Vincent, J.P.; Moorhouse, L.; Shimakawa, Y.; Nayagam, S. Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health. 2023, 11, e715–e728. [Google Scholar] [CrossRef]
- Indolfi, G.; Easterbrook, P.; Dusheiko, G.; Siberry, G.; Chang, M.-H.; Thorne, C.; et al. Hepatitis B virus infection in children and adolescents. The Lancet Gastroenterology & Hepatology. 2019, 4, 466–476. [Google Scholar]
- Hou, J.; Liu, Z.; Gu, F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005, 2, 50–57. [Google Scholar] [CrossRef]
- Shepard, C.W.; Finelli, L.; Fiore, A.E.; Bell, B.P. Epidemiology of Hepatitis B and Hepatitis B Virus Infection in United States Children. The Pediatric Infectious Disease Journal. 2005, 24, 755–760. [Google Scholar] [CrossRef]
- Allain, J.-P.; Opare-Sem, O. Screening and diagnosis of HBV in low-income and middle-income countries. Nature Reviews Gastroenterology & Hepatology. 2016, 13, 643–653. [Google Scholar]
- Terrault, N.A.; Lok, A.S.F.; McMahon, B.J.; Chang, K.M.; Hwang, J.P.; Jonas, M.M.; et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67, 1560–1599. [Google Scholar] [CrossRef] [PubMed]
- Morikawa, K.; Shimazaki, T.; Takeda, R.; Izumi, T.; Umumura, M.; Sakamoto, N. Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection. Ann Transl Med. 2016, 4, 337. [Google Scholar] [CrossRef]
- Zhang, Z.; Wang, C.; Liu, Z.; Zou, G.; Li, J.; Lu, M. Host Genetic Determinants of Hepatitis B Virus Infection. Frontiers in Genetics. 2019, 10. [Google Scholar] [CrossRef]
- Global, W. Hepatitis Report; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
- Jaquet, A.; Muula, G.; Ekouevi, D.K.; Wandeler, G. Elimination of viral hepatitis in low and middle-income countries: epidemiological research gaps. Current epidemiology reports. 2021, 8, 89–96. [Google Scholar] [CrossRef]
- Mutisya, I.; Muthoni, E.; Ondondo, R.O.; Muthusi, J.; Omoto, L.; Pahe, C.; et al. A national household survey on HIV prevalence and clinical cascade among children aged≤ 15 years in Kenya (2018). Plos one. 2022, 17, e0277613. [Google Scholar] [CrossRef]
- Schweitzer, A.; Horn, J.; Mikolajczyk, R.T.; Krause, G.; Ott, J.J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet. 2015, 386, 1546–1555. [Google Scholar] [CrossRef]
- Kazmi, S.A.; Rauf, A.; Alshahrani, M.M.; Awadh, A.A.A.; Iqbal, Z.; Soltane, R.; et al. Hepatitis B among University Population: Prevalence, Associated Risk Factors, Knowledge Assessment, and Treatment Management. Viruses. 2022, 14, 1936. [Google Scholar] [CrossRef] [PubMed]
- Brown, R.; Goulder, P.; Matthews, P.C. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts. Wellcome Open Res. 2022, 7, 32. [Google Scholar] [CrossRef] [PubMed]
- Liu, M.; Li, L.; Zhao, J.; Ungvari, G.S.; Ng, C.H.; Duan, Z.; et al. Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China. PeerJ. 2022, 10, e13828. [Google Scholar] [CrossRef] [PubMed]
- Ruggieri, A.; Barbati, C.; Malorni, W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. International journal of cancer. 2010, 127, 499–504. [Google Scholar] [CrossRef]
- Blumberg, B.S. Sex differences in response to hepatitis b virus. Arthritis & Rheumatism. 1979, 22, 1261–1266. [Google Scholar]
- Xu, X.; Wu, C.; Lou, Z.; Peng, C.; Jiang, L.; Wu, T.; et al. Changing incidence of hepatitis B and persistent infection risk in adults: a population-based follow-up study from 2011 in China. BMC Public Health. 2023, 23, 256. [Google Scholar] [CrossRef]
- Stroffolini, T.; Esvan, R.; Biliotti, E.; Sagnelli, E.; Gaeta, G.B.; Almasio, P.L. Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease. Journal of medical virology. 2015, 87, 1899–1903. [Google Scholar] [CrossRef] [PubMed]
- Chu, C.-M.; Sheen, I.-S.; Lin, S.-M.; Liaw, Y.-F. Sex Difference in Chronic Hepatitis B Virus Infection: Studies of Serum HBeAg and Alanine Aminotransferase Levels in 10,431 Asymptomatic Chinese HBsAg Carriers. Clinical Infectious Diseases. 1993, 16, 709–713. [Google Scholar] [CrossRef]
- Tang, L.S.Y.; Covert, E.; Wilson, E.; Kottilil, S. Chronic Hepatitis B Infection: A Review. JAMA. 2018, 319, 1802–1813. [Google Scholar] [CrossRef]
- Abel, A.G.; Shamarina, S.; Hisham, M.; Hafiz, A.R.A. Prevalence and Associated Risk Factors of Hepatitis B Virus Infection In Lafia Metropolis, Nasarawa State, Nigeria. Afr J Infect Dis. 2025, 19, 45–56. [Google Scholar]
- World Health Organization. Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination; World Health Organization: Geneva, 2015. [Google Scholar]
- Seto, W.-K.; Lo, Y.-R.; Pawlotsky, J.-M.; Yuen, M.-F. Chronic hepatitis B virus infection. The Lancet. 2018, 392, 2313–2324. [Google Scholar] [CrossRef] [PubMed]
- Athalye, S.; Khargekar, N.; Shinde, S.; Parmar, T.; Chavan, S.; Swamidurai, G.; et al. Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: implications and perspective. Journal of Infection and Public Health. 2023, 16, 1109–1114. [Google Scholar] [CrossRef]
- Mangowi, I.; Mirambo, M.M.; Kilonzo, S.B.; Mlewa, M.; Nyawale, H.; Majinge, D.; et al. Hepatitis B virus infection, associated factors, knowledge and vaccination status among household contacts of hepatitis B index cases in Mwanza, Tanzania. IJID Regions. 2024, 10, 168–173. [Google Scholar] [CrossRef]
- Sofian, M.; Banifazl, M.; Ziai, M.; Aghakhani, A.; Farazi, A.A.; Ramezani, A. Intra-familial Transmission of Hepatitis B Virus Infection in Arak, Central Iran. Iran J Pathol. 2016, 11, 328–333. [Google Scholar]
- Morgan, C.E.; Ngimbi, P.; Boisson-Walsh, A.J.N.; Ntambua, S.; Matondo, J.; Tabala, M.; et al. Hepatitis B Virus Prevalence and Transmission in the Households of Pregnant Women in Kinshasa, Democratic Republic of Congo. Open Forum Infect Dis. 2024, 11, ofae150. [Google Scholar] [CrossRef] [PubMed]
- Jafari, S.; Buxton, J.A.; Afshar, K.; Copes, R.; Baharlou, S. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health. 2012, 103, 207–212. [Google Scholar] [CrossRef] [PubMed]
- Chuang, S.C.; Lee, Y.C.; Hashibe, M.; Dai, M.; Zheng, T.; Boffetta, P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010, 19, 1261–1268. [Google Scholar] [CrossRef]
- Liu, X.; Baecker, A.; Wu, M.; Zhou, J.Y.; Yang, J.; Han, R.Q.; et al. Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population. Int J Cancer. 2018, 142, 1560–1567. [Google Scholar] [CrossRef]


| Variables | N | % | HBsAg+ n | % | cPR | 95% CI | p-value | aPR | 95%CI | p- value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Region (n=3033) | ||||||||||
| Baringo | 2788 | 91.94 | 189 | 6.78 | 1 | REF | ||||
| Kisumu | 245 | 8.06 | 3 | 1.22 | 0.18 | 0.06,0.56 | 0.003 | |||
| 2. Sex (n=3033) | ||||||||||
| Female | 1969 | 65.39 | 122 | 6.20 | 1 | REF | ||||
| Male | 1042 | 34.61 | 69 | 6.62 | 0.94 | 0.70,1.24 | 0.648 | |||
| 3. Education Level (n=2560) | ||||||||||
| Up to Primary | 1195 | 46.66 | 86 | 7.29 | 0.998 | 0.65,1.54 | 0.995 | 0.67 | 0.42,1.06 | 0.085 |
| Secondary | 1031 | 40.28 | 52 | 5.04 | 0.70 | 0.50,0.98 | 0.037 | 1 | REF | |
| College | 334 | 13.05 | 24 | 7.19 | 1 | REF | ||||
| 4. Marital status (n=3002) | ||||||||||
| Never married | 425 | 14.16 | 16 | 3.19 | 1 | REF | 1 | REF | ||
| Married | 2431 | 80.98 | 169 | 6.95 | 2.18 | 1,31, 3.60 | 0.002 | 1 | ||
| Once married | 146 | 4.86 | 3 | 4.35 | 1.36 | 0.41, 4.55 | 0.616 | 1.36 | 0.47,3.05 | 0.568 |
| 5. Age of youngest child (n=1891) | ||||||||||
| >5 years | 682 | 36.07 | 49 | 7.18 | 1 | REF | ||||
| ≤5 years | 1209 | 63.93 | 95 | 7.86 | 1.1 | 0.77, 1.58 | 0.596 | |||
| 6. Number of siblings in the family (n=2872) | ||||||||||
| <5 | 1597 | 55.61 | 71 | 4.45 | 1 | REF | 1 | REF | ||
| 5 - 10 | 1153 | 40.15 | 97 | 8.41 | 1.89 | 1.44, 2.71 | <0.001 | 1.40 | 0.65, 3.05 | 0.390 |
| >10 | 122 | 4.25 | 9 | 7.38 | 2.17 | 1.34, 3.51 | 0.001 | 1.43 | 0.26, 7.83 | 0.681 |
| 7. Employment (n= 2969) | ||||||||||
| Formal (Salaried) | 301 | 10.14 | 19 | 6.31 | 1 | REF | ||||
| Informal (Self Employed) | 830 | 27.93 | 62 | 7.47 | 1.18 | 0.72,1.94 | 0.507 | |||
| unemployed | 1838 | 61.93 | 105 | 5.71 | 0.91 | 0.56,1.45 | 0.679 | |||
| 8.Net monthly income (USD) of the unemployed | ||||||||||
| <50 | 259 | 23.14 | 12 | 4.63 | 1 | REF | ||||
| 51-100 | 477 | 42.63 | 40 | 8.39 | 1.81 | 0.97, 3.39 | 0.064 | |||
| >101 | 383 | 34.23 | 28 | 7.31 | 1.57 | 0.82, 3.03 | 0.177 | |||
| 9. Distance | ||||||||||
| < 1 km | 96 | 96 | 2 | 2.08 | 1 | REF | 1 | REF | ||
| 1 - 5 km | 1046 | 1046 | 44 | 4.21 | 2.06 | 0.49, 8.65 | 0.322 | 2.30 | 0.52, 10.06 | 0.271 |
| > 5 km | 171 | 171 | 23 | 13.45 | 7.3 | 1.68, 31.70 | 0.008 | 10.44 | 2.26, 49.37 | 0.003 |
| 10. Age category using the median (n=2987) | ||||||||||
| ≤37 years | 1559 | 1559 | 82 | 5.26 | 1 | |||||
| > 37 years | 1428 | 1428 | 107 | 7.49 | 2.191 | |||||
| 11. Age category (n=2987) | ||||||||||
| ≤19 | 167 | 5.59 | 3 | 1.80 | 1 | REF | 1 | REF | ||
| 20-29 | 797 | 26.62 | 37 | 9.26 | 2.67 | 0.81,8.76 | 0.106 | 0.33, 8.27 | 0.546 | |
| 30-39 | 716 | 23.97 | 53 | 14.85 | 4.37 | 1.35, 14.16 | 0.014 | 1.58 | 0.28, 9.03 | 0.605 |
| 40-49 | 415 | 13.89 | 43 | 21.44 | 6.32 | 1.93, 20.66 | 0.002 | |||
| 50-59 | 363 | 12.15 | 26 | 13.78 | 4.21 | 1.26, 14.14 | 0.020 | 1.04 | 0.15, 7.10 | 0.701 |
| <60-75 | 531 | 17.77 | 27 | 23.47 | 2.93 | 0.88,9.78 | 0.081 | 0.56 | 0.07, 4.51 | 0.586 |
| REF = Reference variable | ||||||||||
| Family Name¤ | Parents’ HBV status | No. of infected siblings | Family members infected * | |||
|---|---|---|---|---|---|---|
| Mother | Father | Male n/total | Female n/total | Infection among siblings | ||
| Family 1 | Negative | Infected | 1/5 | 1/5 | 2/5 (40.0%) | 3/7 (42.9%) |
| Family 2 | Negative | Negative | 3/6 | 1/6 | 4/6 (66.7%) | 4/8 (50.0%) |
| Family 3 | NT | NT | 1/7 | 2/7 | 3/7 (42.9%) | 3/7 (42.9%) |
| Family 4 | Deceased of HCC | Negative | 1/4 | 3/4 | 4/4 (100%) | 3/5 (50.0%) |
| Family 5 | Negative | Infected | 2/6 | 1/6 | 3/6 (50.0%) | 4/8 (50.0%) |
| Family 6 | Deceased | Deceased | - | 1/2 | ½ (50.0%) | ½ (50.0%) |
| Total | 1/6 | 2/6 | 17/30 (56.7%) | 18/37 (48.6%) | ||
| Variables | N | (%) | HBsAg Positive | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| HBsAg+ n |
HBsAg+ (%) |
cPR | 95%CI | P value | aPR | 95% CI | P value | |||
| Sharing household items (n=3034) | ||||||||||
| no | 2561 | (84.41) | 145 | (5.66) | 1 | REF | 1 | REF | ||
| yes | 473 | (15.59) | 47 | (9.94) | 1.76 | 1.29,2.40 | <0.001 | 2.60 | 1.54,4.39 | <0.001 |
| Hair dressing and Shaving (n=3007) | ||||||||||
| Do it myself | 112 | (3.72) | 8 | (7.14) | 1 | REF | ||||
| I Use barber/saloon | 2643 | (87.89) | 163 | (4.17) | 0.86 | 0.44, 1.71 | 0.674 | |||
| Not applicable | 252 | (8.38) | 13 | (5.16) | 0.72 | 0.30, 1.69 | 0.454 | |||
| Traditional Circumcision (n=3034) | ||||||||||
| no | 1048 | (34.85) | 48 | (4.58) | 1 | REF | 1 | REF | ||
| yes | 1959 | (65.15) | 139 | (7.1) | 1.55 | 1.13,2.13 | 0.007 | 1.02 | 0.56,1.88 | 0.040 |
| Shared circumcision sharps (n=1956) | ||||||||||
| no | 1228 | (62.78) | 92 | (7.49) | 1 | REF | ||||
| yes | 728 | (37.22) | 47 | (6.46) | 0.86 | 0.61, 1.21 | 0.390 | |||
| Where circumcision took place (n=1933) | ||||||||||
| Home | 1918 | (98.06) | 137 | (7.14) | 1 | REF | ||||
| Hospital | 15 | (0.77) | 0 | (0) | 1 | <0.001 | ||||
| Number of sexual partners (n=454) | ||||||||||
| none | 302 | (66.52) | 17 | (5.63) | 1 | REF | ||||
| Two | 111 | (24.45) | 7 | (6.31) | 1.12 | 0.48,2.63 | 0.794 | |||
| > 2 | 41 | (9.03) | 3 | (7.32) | 1.30 | 0.40,4.25 | 0.664 | |||
| History of Alcohol Consumption (n=3034) | ||||||||||
| no | 2307 | (76.72) | 133 | (5.77) | 1 | REF | 1 | REF | ||
| yes | 700 | (23.28) | 56 | (8.00) | 1.39 | 1.03,1.88 | 0.032 | 1.32 | 0.76,2.32 | 0.320 |
| Frequency of alcohol uptake (n=700) | ||||||||||
| daily | 83 | (11.86) | 8 | (9.64) | 1 | REF | ||||
| after 2 days | 18 | (2.57) | 1 | (5.56) | 0.58 | 0.08, 4.35 | 0.593 | |||
| weekly | 33 | (4.71) | 1 | (3.03) | 0.31 | 0.04, 2.42 | 0.267 | |||
| fortnightly | 15 | (2.14) | 2 | (13.33) | 1.38 | 0.32, 5.91 | 0.661 | |||
| at times | 551 | (78.71 | 5 | (9.62) | 0.99 | 0.34, 2.90 | 0.996 | |||
| History of smoking or use of tobacco (n=3034) | ||||||||||
| No | 2893 | (96.18) | 181 | (6.26) | 1 | REF | ||||
| Yes | 115 | (3.82) | 7 | (6.09) | 0.98 | 0.47, 2.04 | 0.961 | |||
| Received transfused blood (n=3034) | ||||||||||
| no | 2871 | (95.57) | 183 | (6.37) | 1 | REF | ||||
| yes | 133 | (4.43) | 6 | (4.51) | 0.70 | 0.32, 1.57 | 0.394 | |||
| Are you diabetic? (n=3034) | ||||||||||
| no | 2987 | (99.63) | 187 | (6.26) | 1 | REF | ||||
| yes | 11 | (0.37) | 2 | (18.18) | 2.90 | 0.82,10.25 | 0.098 | |||
| Sharing diabetic needle (n= 11) | ||||||||||
| no | 10 | (90.00) | 2 | (18.18) | 1 | REF | <0.001 | |||
| yes | 1 | (10.00) | 0 | (0.00) | 1 | |||||
| Use of other injectable drugs (n=3034) | ||||||||||
| no | 2992 | (99.73) | 186 | (6.22) | 1 | REF | 1 | REF | ||
| yes | 8 | (0.27) | 2 | (25.00) | 4.02 | 1.20,13.47 | 0.024 | 6.71 | 1.34, 33.67 | 0.021 |
| Know your HIV status (n=3005) | ||||||||||
| no | 1329 | (44.17) | 89 | (6.70) | 1 | REF | ||||
| yes | 1676 | (55.83) | 100 | (5.97) | 0.89 | 0.68, 1.17 | 0.411 | |||
| HIV status if known (n=1680) | ||||||||||
| negative | 1619 | (96.37) | 97 | (5.99) | 1 | REF | ||||
| positive | 61 | (3.63) | 3 | (4.92) | 1.22 | 0.40, 3.73 | 0.730 | |||
| Are you a health care worker (n=3034) | ||||||||||
| no | 3006 | (99.08) | 191 | (6.35) | 1 | REF | ||||
| yes | 28 | (0.92) | 1 | (3.57) | 0.58 | 0.08,4.01 | 0.584 | |||
| History of Incarceration (n=3004) | ||||||||||
| No | 2933 | (97.64) | 188 | (6.41) | 1 | REF | ||||
| Yes | 71 | (2.36) | 1 | (1.41) | 0.22 | 0.03, 1.54 | 0.128 | |||
| Have tattoos or traditional scarification (n=3034) | ||||||||||
| no | 2962 | (99.10) | 187 | (6.31) | 1 | REF | ||||
| yes | 27 | (0.90) | 2 | (7.41) | 1.17 | 0.31, 4.49 | 0.815 | |||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).